Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →GFL reported Q1 FY25 consolidated revenue of INR 1,176 crore (up 4% QoQ) and EBITDA of INR 262 crore (up 10% QoQ), with EBITDA margin at 22%.
✓ Verified against BSE filing
GFL reported Q1 FY25 consolidated revenue of INR 1,176 crore (up 4% QoQ) and EBITDA of INR 262 crore (up 10% QoQ), with EBITDA margin at 22%. PAT stood at INR 108 crore (up 7% QoQ). The sequential improvement was driven by a pickup in refrigerant volumes and prices, and continued growth in fluoropolymers, partially offset by logistics disruptions from the Red Sea crisis (impacting ~INR 70-80 crore revenue). Management reiterated confidence in reaching FY23 EBITDA run-rate of INR 1,700-1,800 crore by Q4 FY25, driven by fluoropolymer capacity utilization and new EV battery material supplies (LiPF6, electrolyte, PVDF) expected from Q4 FY25. Key risks include slower-than-expected ramp-up in battery materials and persistent Chinese competition in base fluoropolymers.
जीएफएल ने पहली तिमाही में 1,176 करोड़ रुपये की कमाई की, जो पिछली तिमाही से 4% ज़्यादा है। कंपनी ने 262 करोड़ रुपये का परिचालन लाभ कमाया, जो 10% बढ़ा। इसका मतलब है कि हर 100 रुपये की कमाई पर 22 रुपये का मुनाफ़ा हुआ। शुद्ध मुनाफ़ा 108 करोड़ रुपये रहा, जो 7% ज़्यादा है। यह सुधार रेफ्रिजरेंट की बिक्री और कीमतों में बढ़ोतरी और फ्लोरोपॉलीमर के कारोबार में लगातार वृद्धि से हुआ। हालांकि, लाल सागर संकट से आपूर्ति में रुकावट के कारण 70-80 करोड़ रुपये का नुकसान हुआ। कंपनी को उम्मीद है कि मार्च 2025 तक सालाना परिचालन लाभ 1,700-1,800 करोड़ रुपये तक पहुंच जाएगा। यह नई बैटरी सामग्री (LiPF6, इलेक्ट्रोलाइट, PVDF) की बिक्री से संभव होगा। जोखिमों में बैटरी सामग्री की बिक्री में देरी और चीनी कंपनियों से कड़ी प्रतिस्पर्धा शामिल है।
0 delivered, 0 close, 2 missed.
View Promises →Slow ramp-up in battery materials
View Risks →Full transcript text is available on this route.
Read Transcript →Revenue not booked due to shipping delays from Red Sea crisis, as disclosed by CEO.
Number of potential customers engaged across US, EU, Japan, Korea, and India for battery materials.
Product samples shipped globally for validation in battery materials segment.
Expected annual savings from renewable energy contracts starting next year, per CEO.
Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.
The LFP plant is expected to be commissioned in the third quarter of this financial year.
Management expects to substantially utilize new fluoropolymer capacities by Q4 FY25.
LiPF6, electrolyte, and PVDF binder commercial supplies expected to commence from Q4 FY2025.
Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.
Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.
Green shoots visible; destocking phasing out. New capacities in FKM, PFA, PVDF, and micropowders to drive volume and value growth.
Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.
Analyst raised concern about Chinese capacity additions pressuring pricing; management downplayed impact by focusing on high-value segments.
Shipping delays via Cape of Good Hope caused ~INR 70-80 crore revenue deferment in Q1; may persist.
Investor asked about PFAS phase-out concerns; management argued fluoropolymers are exempt but acknowledged potential indirect impact.
Imports of lower-end grades (e.g., granular PTFE) continue to pressure domestic pricing and margins.
U.S. duty cuts and R-22 quota phase-out keep refrigerant prices subdued; no improvement expected in FY25.
Analyst raised concern about high net debt-to-EBITDA (1.8x) and INR 800 crore CapEx; management confirmed external funding process but no guarantee.
Q4 operating costs rose due to year-end provisions, CSR, Red Sea logistics, and new plant expenses; sustainability unclear.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.
Mentioned in Q3 FY24, Q4 FY24
Funding to be raised externally; investment bankers appointed. CapEx plan remains on track.
Mentioned in Q1 FY24, Q3 FY24
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
Mentioned in Q3 FY24, Q4 FY24
Management expects EBITDA to recover to FY23 levels, driven by fluoropolymer volume growth and new capacity ramp-up.
Mentioned in Q2 FY24, Q4 FY24
Imports of lower-end grades (e.g., granular PTFE) continue to pressure domestic pricing and margins.
Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.
Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.
View Risks →